ISTA Vitrase Data Subgroup Analysis Could Support Efficacy, Cmte. Says
Executive Summary
A subgroup analysis of Allergan/ISTA's Vitrase data could provide additional evidence for efficacy of the ophthalmic drug for treatment of vitreous hemorrhage, FDA's Dermatologic & Ophthalmic Drugs Advisory Committee said March 17